AERKOMM and Nasdaq-Listed IX Acquisition Corp. Announce Merger Agreement and US $35 Million Private Placement
March 29, 2024 10:00 ET
|
IX Acquisition Corp.
SILICON VALLEY, Calif., March 29, 2024 (GLOBE NEWSWIRE) -- AERKOMM Inc. (Euronext: AKOM, OTCQX: AKOM, “AERKOMM”), an innovative satellite technology company providing multi-orbit broadband...
Lee Enterprises Adopts Limited-Duration Shareholder Rights Plan
March 29, 2024 10:00 ET
|
Lee Enterprises Inc.
DAVENPORT, Iowa, March 29, 2024 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ: LEE) (“Lee” or the “Company”), today announced that its Board of Directors (the “Board”) has unanimously...
ASML reports transactions under its current share buyback program
March 29, 2024 09:00 ET
|
ASML Netherlands BV
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share...
SB Financial Group, Inc. Announces Schedule for First Quarter 2024 Results
March 29, 2024 09:00 ET
|
SB Financial Group, Inc.
DEFIANCE, Ohio, March 29, 2024 (GLOBE NEWSWIRE) -- SB Financial Group, Inc. (NASDAQ: SBFG), a diversified financial services company providing full-service community banking, mortgage banking,...
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
March 29, 2024 09:00 ET
|
Adagene Inc.
- Data for masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) highlight best-in-class therapeutic index and demonstrate clinical benefits in metastatic microsatellite-stable (MSS) colorectal cancer...
Professional Diversity Network, Inc. Announces Financial Results for the Quarter and Fiscal Year Ended December 31, 2023
March 29, 2024 09:00 ET
|
Professional Diversity Network, Inc.
Earning Release of the 4th Quarter of 2023
Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates
March 29, 2024 08:30 ET
|
Elicio Therapeutics, Inc.
ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual Meeting 2024ELI-007 and ELI-008 preclinical data were accepted for a poster presentation at the AACR...
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
March 29, 2024 08:21 ET
|
Molecular Templates, Inc.
AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and...
BurgerFi to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
March 29, 2024 08:00 ET
|
BurgerFi International
FORT LAUDERDALE, Fla., March 29, 2024 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi”), owner of one of the nation’s leading fast-casual “better burger” dining...
Gentex Schedules First Quarter 2024 Earnings Release Date and Conference Call
March 29, 2024 08:00 ET
|
Gentex Corporation
Gentex schedules Q1 2024 earnings release and conference call for April 26.